178 related articles for article (PubMed ID: 31202709)
1. O-GlcNAcylation of ITGA5 facilitates the occurrence and development of colorectal cancer.
Yu M; Chu S; Fei B; Fang X; Liu Z
Exp Cell Res; 2019 Sep; 382(2):111464. PubMed ID: 31202709
[TBL] [Abstract][Full Text] [Related]
2. Decreasing O-GlcNAcylation affects the malignant transformation of MCF-7 cells via Hsp27 expression and its O-GlcNAc modification.
Netsirisawan P; Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2018 Oct; 40(4):2193-2205. PubMed ID: 30106436
[TBL] [Abstract][Full Text] [Related]
3. O-GlcNAcylation promotes colorectal cancer metastasis via the miR-101-O-GlcNAc/EZH2 regulatory feedback circuit.
Jiang M; Xu B; Li X; Shang Y; Chu Y; Wang W; Chen D; Wu N; Hu S; Zhang S; Li M; Wu K; Yang X; Liang J; Nie Y; Fan D
Oncogene; 2019 Jan; 38(3):301-316. PubMed ID: 30093632
[TBL] [Abstract][Full Text] [Related]
4. O-GlcNAcylation Enhances NUSAP1 Stability and Promotes Bladder Cancer Aggressiveness.
Chen Y; Liu J; Zhang W; Kadier A; Wang R; Zhang H; Yao X
Onco Targets Ther; 2021; 14():445-454. PubMed ID: 33488099
[TBL] [Abstract][Full Text] [Related]
5. Differential membranous E-cadherin expression, cell proliferation and O-GlcNAcylation between primary and metastatic nodal lesion in colorectal cancer.
Jang TJ
Pathol Res Pract; 2016 Feb; 212(2):113-9. PubMed ID: 26724145
[TBL] [Abstract][Full Text] [Related]
6. O-GlcNAcylation is associated with the development and progression of gastric carcinoma.
Jang TJ; Kim UJ
Pathol Res Pract; 2016 Jul; 212(7):622-30. PubMed ID: 27131860
[TBL] [Abstract][Full Text] [Related]
7. Reciprocal Regulation Between O-GlcNAcylation and β-Catenin Facilitates Cell Viability and Inhibits Apoptosis in Liver Cancer.
Gao S; Miao Y; Liu Y; Liu X; Fan X; Lin Y; Qian P; Zhou J; Dai Y; Xia L; Zhu P; Zhu J
DNA Cell Biol; 2019 Apr; 38(4):286-296. PubMed ID: 30762425
[TBL] [Abstract][Full Text] [Related]
8. Elevated O-GlcNAcylation promotes gastric cancer cells proliferation by modulating cell cycle related proteins and ERK 1/2 signaling.
Jiang M; Qiu Z; Zhang S; Fan X; Cai X; Xu B; Li X; Zhou J; Zhang X; Chu Y; Wang W; Liang J; Horvath T; Yang X; Wu K; Nie Y; Fan D
Oncotarget; 2016 Sep; 7(38):61390-61402. PubMed ID: 27542217
[TBL] [Abstract][Full Text] [Related]
9. O-GlcNAcylation affects β-catenin and E-cadherin expression, cell motility and tumorigenicity of colorectal cancer.
Harosh-Davidovich SB; Khalaila I
Exp Cell Res; 2018 Mar; 364(1):42-49. PubMed ID: 29391154
[TBL] [Abstract][Full Text] [Related]
10. Potential role of O-GlcNAcylation and involvement of PI3K/Akt1 pathway in the expression of oncogenic phenotypes of gastric cancer cells in vitro.
Zhang N; Chen X
Biotechnol Appl Biochem; 2016 Nov; 63(6):841-851. PubMed ID: 26333304
[TBL] [Abstract][Full Text] [Related]
11. IDH2, a novel target of OGT, facilitates glucose uptake and cellular bioenergy production via NF-κB signaling to promote colorectal cancer progression.
He X; Wu N; Li R; Zhang H; Zhao Y; Nie Y; Wu J
Cell Oncol (Dordr); 2023 Feb; 46(1):145-164. PubMed ID: 36401762
[TBL] [Abstract][Full Text] [Related]
12. Suppressed OGT expression inhibits cell proliferation while inducing cell apoptosis in bladder cancer.
Wang L; Chen S; Zhang Z; Zhang J; Mao S; Zheng J; Xuan Y; Liu M; Cai K; Zhang W; Guo Y; Zhai W; Yao X
BMC Cancer; 2018 Nov; 18(1):1141. PubMed ID: 30453909
[TBL] [Abstract][Full Text] [Related]
13. OGT-mediated O-GlcNAcylation promotes NF-κB activation and inflammation in acute pancreatitis.
Zhang D; Cai Y; Chen M; Gao L; Shen Y; Huang Z
Inflamm Res; 2015 Dec; 64(12):943-52. PubMed ID: 26407569
[TBL] [Abstract][Full Text] [Related]
14. Overexpression of Fatty Acid Synthase Upregulates Glutamine-Fructose-6-Phosphate Transaminase 1 and O-Linked N-Acetylglucosamine Transferase to Increase O-GlcNAc Protein Glycosylation and Promote Colorectal Cancer Growth.
Drury J; Geisen ME; Tessmann JW; Rychahou PG; Kelson CO; He D; Wang C; Evers BM; Zaytseva YY
Int J Mol Sci; 2024 Apr; 25(9):. PubMed ID: 38732103
[TBL] [Abstract][Full Text] [Related]
15. Down-regulation of FN1 inhibits colorectal carcinogenesis by suppressing proliferation, migration, and invasion.
Cai X; Liu C; Zhang TN; Zhu YW; Dong X; Xue P
J Cell Biochem; 2018 Jun; 119(6):4717-4728. PubMed ID: 29274284
[TBL] [Abstract][Full Text] [Related]
16. mTOR/MYC Axis Regulates O-GlcNAc Transferase Expression and O-GlcNAcylation in Breast Cancer.
Sodi VL; Khaku S; Krutilina R; Schwab LP; Vocadlo DJ; Seagroves TN; Reginato MJ
Mol Cancer Res; 2015 May; 13(5):923-33. PubMed ID: 25636967
[TBL] [Abstract][Full Text] [Related]
17. Alteration of O-GlcNAcylation affects serine phosphorylation and regulates gene expression and activity of pyruvate kinase M2 in colorectal cancer cells.
Chaiyawat P; Chokchaichamnankit D; Lirdprapamongkol K; Srisomsap C; Svasti J; Champattanachai V
Oncol Rep; 2015 Oct; 34(4):1933-42. PubMed ID: 26252736
[TBL] [Abstract][Full Text] [Related]
18. Integrin α5 subunit is required for the tumor supportive role of fibroblasts in colorectal adenocarcinoma and serves as a potential stroma prognostic marker.
Lu L; Xie R; Wei R; Cai C; Bi D; Yin D; Liu H; Zheng J; Zhang Y; Song F; Gao Y; Tan L; Wei Q; Qin H
Mol Oncol; 2019 Dec; 13(12):2697-2714. PubMed ID: 31600854
[TBL] [Abstract][Full Text] [Related]
19. Relationship between the expression of the extracellular matrix genes SPARC, SPP1, FN1, ITGA5 and ITGAV and clinicopathological parameters of tumor progression and colorectal cancer dissemination.
Viana Lde S; Affonso RJ; Silva SR; Denadai MV; Matos D; Salinas de Souza C; Waisberg J
Oncology; 2013; 84(2):81-91. PubMed ID: 23128103
[TBL] [Abstract][Full Text] [Related]
20. O-GlcNAcylation enhances the invasion of thyroid anaplastic cancer cells partially by PI3K/Akt1 pathway.
Zhang P; Wang C; Ma T; You S
Onco Targets Ther; 2015; 8():3305-13. PubMed ID: 26635480
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
